Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057

Sort by:

Global Pharmaceutical Grade Fulvic Acid Market Report 2018

US$ 2,350.00

... ) Section (5 6 7): 500 USD—— Product Type Segmentation (High Purity Pharmaceutical Grade Fulvic Acid, Low Purity Pharmaceutical Grade Fulvic Acid) Industry Segmentation (Medicine, Health Care Products, Others) Channel ...

February 2018 123 pages

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) – Pipeline Review, H1 2018

US$ 3,500.00

... Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 90 pages

MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) – Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) development landscape Develop and design ...

February 2018 37 pages

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) development ...

February 2018 120 pages

DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2018

US$ 3,500.00

... DNA Gyrase Subunit B (EC 5.99.1.3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 25 pages

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential – Forecast to 2023

US$ 2,000.00

... report titled “Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential – Forecast to 2023” presents the market potential of six major pipeline drugs meant for ...

February 2018 120 pages

Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 77 pages

Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) targeted therapeutics development with ...

February 2018 65 pages

Cyclin Dependent Kinase 1 (p34 Protein Kinase or Cell Division Protein Kinase 1 or Cell Division Control Protein 2 Homolog or CDK1 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cyclin Dependent Kinase 1 (p34 Protein Kinase or Cell Division Protein Kinase 1 or Cell Division Control Protein 2 Homolog or CDK1 or EC 2.7.11.22 or EC 2.7.11.23) development ...

February 2018 49 pages

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Pipeline Review, H1 2018

US$ 3,500.00

... Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 63 pages

Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) development landscape Develop and design ...

February 2018 110 pages

Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeline Review, H1 2018

US$ 3,500.00

... key players involved in Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase 1 or CDK7 or EC 2.7.11.22 or EC 2.7.11.23) targeted therapeutics development ...

February 2018 60 pages

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Pipeline Review, H1 2018

US$ 3,500.00

... . It also reviews key players involved in Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) targeted therapeutics development with respective active ...

February 2018 38 pages

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) development ...

February 2018 51 pages

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H1 2018

US$ 3,500.00

... key players involved in Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) targeted therapeutics development with respective active ...

February 2018 45 pages

Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) development landscape Develop ...

February 2018 58 pages

RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) development landscape Develop and ...

February 2018 52 pages

RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 55 pages

Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or EC 2.7.11.1) development landscape Develop ...

February 2018 62 pages

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 74 pages

Global Drug Infusion Systems Market: Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast (2017-2025)

US$ 4,599.00

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. The increased prevalence of chronic diseases...

February 2018 355 pages

2018-2023 China Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In China market, the top players ...

February 2018 83 pages

2018-2023 Global Top Countries Depression Drugs Market Report

US$ 4,960.00

... USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Depression Drugs in Global market, especially in United ... Middle East and Africa, focuses on the top Players in each country, covering Intellipharmaceutics Pfizer Eli Lilly Astrazeneca Lundbeck Allergan GSK ...

February 2018 110 pages

2018-2023 India Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players ...

February 2018 83 pages

2018-2023 Malaysia Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the top players ...

February 2018 83 pages

2018-2023 Philippines Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players ...

February 2018 83 pages

2018 Top 5 Depression Drugs Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

US$ 4,960.00

... in 48 hours after order is placed. The Global Depression Drugs market size will be XX million (USD) in 2023 ... 2023. This report studies the global Depression Drugs market, especially in North America, Europe ... 5 Depression Drugs players in each region, with sales, price, revenue and market share from 2013 to 2018, ...

February 2018 110 pages

2018-2023 UK Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players ...

February 2018 83 pages

2018-2023 United States Depression Drugs Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the Depression Drugs market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the ...

February 2018 83 pages

Pharmaceutical AGV-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Pharmaceutical AGV market as: Asia Pacific Pharmaceutical AGV Market ...

February 2018 132 pages

Pharmaceutical AGV-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Pharmaceutical AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the China Pharmaceutical AGV market as: China Pharmaceutical AGV Market ...

February 2018 152 pages

Pharmaceutical AGV-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Pharmaceutical AGV-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical AGV industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 154 pages

Pharmaceutical AGV-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Pharmaceutical AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the Europe Pharmaceutical AGV market as: Europe Pharmaceutical AGV Market ...

February 2018 137 pages

Pharmaceutical AGV-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Pharmaceutical AGV-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical AGV industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 160 pages

Pharmaceutical AGV-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Pharmaceutical AGV-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pharmaceutical AGV industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 156 pages

Pharmaceutical AGV-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Pharmaceutical AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the India Pharmaceutical AGV market as: India Pharmaceutical AGV Market ...

February 2018 153 pages

Pharmaceutical AGV-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the North America Pharmaceutical AGV market as: North America Pharmaceutical AGV Market ...

February 2018 154 pages

Pharmaceutical AGV-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the South America Pharmaceutical AGV market as: South America Pharmaceutical AGV Market ...

February 2018 139 pages

Pharmaceutical AGV-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... AGV market Market status and development trend of Pharmaceutical AGV by types and applications Cost and profit status of Pharmaceutical AGV, and marketing status Market growth drivers and challenges The report segments the United States Pharmaceutical AGV market as: United States Pharmaceutical AGV Market ...

February 2018 155 pages

North America and Europe Botox Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... . Scope of the Report: This report focuses on the Botox in North America and Europe market, especially in United States, United Kingdom, Canada, ... There are 19 Chapters to deeply display the North America and Europe Botox market. Chapter 1, to describe Botox Introduction, product type and application, market ...

February 2018 108 pages

North America and Europe Active Pharmaceutical Ingredients Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... the Report: This report focuses on the Active Pharmaceutical Ingredients in North America and Europe market, especially in United States, United ... to deeply display the North America and Europe Active Pharmaceutical Ingredients market. Chapter 1, to describe Active Pharmaceutical Ingredients Introduction, ...

February 2018 103 pages

2018-2023 China BCAA Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the BCAA market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In China market, the top players ...

February 2018 85 pages

2018-2023 Global Top Countries BCAA Market Report

US$ 4,960.00

... USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies BCAA in Global market, especially in United States ... , Middle East and Africa, focuses on the top Players in each country, covering Ajinomoto Kyowa Evonik Fufeng Group Luzhou Wuxi Jinghai ...

February 2018 122 pages

2018-2023 Malaysia BCAA Market Report (Status and Outlook)

US$ 3,360.00

... . In 2017, the BCAA market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the top players ...

February 2018 85 pages

2018 Top 5 BCAA Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

US$ 4,960.00

... BCAA players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players ... revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like North America ( ... on sales, market share and growth rate of BCAA in each application, can be divided into Sports ...

February 2018 122 pages

Genitourinary Drugs-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... Drugs market Market status and development trend of Genitourinary Drugs by types and applications Cost and profit status of Genitourinary Drugs, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Genitourinary Drugs market as: Asia Pacific Genitourinary Drugs Market ...

February 2018 159 pages

Genitourinary Drugs-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Genitourinary Drugs market Market status and development trend of Genitourinary Drugs by types and applications Cost and profit status of Genitourinary Drugs, and marketing status Market growth drivers and challenges The report segments the China Genitourinary Drugs market as: China Genitourinary Drugs Market ...

February 2018 141 pages

Genitourinary Drugs-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Genitourinary Drugs-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Genitourinary Drugs industry, standing on the readers’ perspective, delivering detailed market data and ...

February 2018 138 pages

Genitourinary Drugs-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Genitourinary Drugs market Market status and development trend of Genitourinary Drugs by types and applications Cost and profit status of Genitourinary Drugs, and marketing status Market growth drivers and challenges The report segments the Europe Genitourinary Drugs market as: Europe Genitourinary Drugs ...

February 2018 137 pages

Genitourinary Drugs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Genitourinary Drugs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Genitourinary Drugs industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 159 pages

Filters

Clear all